1. Home
  2. OII vs ADPT Comparison

OII vs ADPT Comparison

Compare OII & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oceaneering International Inc.

OII

Oceaneering International Inc.

HOLD

Current Price

$24.68

Market Cap

2.3B

Sector

Energy

ML Signal

HOLD

Logo Adaptive Biotechnologies Corporation

ADPT

Adaptive Biotechnologies Corporation

HOLD

Current Price

$18.80

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OII
ADPT
Founded
1964
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.6B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
OII
ADPT
Price
$24.68
$18.80
Analyst Decision
Hold
Strong Buy
Analyst Count
4
10
Target Price
$25.00
$16.60
AVG Volume (30 Days)
744.0K
2.4M
Earning Date
10-22-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
73.60
N/A
EPS
2.29
N/A
Revenue
$2,829,032,000.00
$252,754,000.00
Revenue This Year
$5.78
$36.43
Revenue Next Year
$1.81
$12.31
P/E Ratio
$10.78
N/A
Revenue Growth
8.71
42.57
52 Week Low
$15.46
$5.81
52 Week High
$30.98
$20.76

Technical Indicators

Market Signals
Indicator
OII
ADPT
Relative Strength Index (RSI) 59.67 61.44
Support Level $22.77 $13.28
Resistance Level $24.95 $20.76
Average True Range (ATR) 0.74 1.08
MACD 0.14 0.45
Stochastic Oscillator 85.07 73.83

Price Performance

Historical Comparison
OII
ADPT

About OII Oceaneering International Inc.

Oceaneering International Inc is a provider of engineered services and products and robotic solutions to the offshore energy, defense, aerospace, manufacturing, and entertainment industries. A majority of its products are produced for the offshore oil and gas market. The company's business segments are Integrity Management and Digital Solutions, Subsea Robotics, Manufactured Products, Offshore Projects Group, and Aerospace and Defense Technologies. Maximum revenue is generated from its Subsea Robotics segment, which provides remotely operated vehicles (ROVs) for drill support and vessel-based services, underwater surveys, tooling, and other activities. Geographically, the company derives its key revenue from the United States, followed by Africa, Norway, Brazil, and other regions.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

Share on Social Networks: